Windlas Biotech Ltd. Financials: Quarterly Results
Windlas Biotech Ltd. Q4FY25 Financial Metrics
Indicator | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 |
---|---|---|---|---|---|
Net Sales/Income from operations (Cr.) | 202.71 | 195.02 | 187 | 175.15 | 171.29 |
Total Income From Operations (Cr.) | 202.71 | 195.02 | 187 | 175.15 | 171.29 |
P/L Before Interest, Excpt. Items & Tax (Cr.) | 22.15 | 21.80 | 21.39 | 18.80 | 22.91 |
P/L Before Exceptional Items & Tax (Cr.) | 20.82 | 20.34 | 20.29 | 18.31 | 22.63 |
P/L After Tax from Ordinary Activities (Cr.) | 16.28 | 15.58 | 15.66 | 13.48 | 16.99 |
Net Profit/Loss For the Period (Cr.) | 16.28 | 15.58 | 15.66 | 13.48 | 16.99 |
Basic EPS | 7.77 | 7.45 | 7.49 | 6.47 | 8.17 |
FAQs
Windlas Biotech Ltd. announced its quarterly results for Q4 FY2025 on May 22, 2025.
In Q4 FY2025, Windlas Biotech Ltd. are as follows:
Revenue: ₹207.65 crore
Net Profit: ₹16.28 crore.
For Q4 FY2025, Windlas Biotech Ltd. posted ₹207.65 crore in revenue and ₹16.28 crore in net profit.
Past quarterly results for Windlas Biotech Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.